{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:28:07Z","timestamp":1792146487767,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T00:00:00Z","timestamp":1236988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00109-009-0456-1","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T10:50:32Z","timestamp":1236941432000},"page":"613-622","source":"Crossref","is-referenced-by-count":8,"title":["A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect"],"prefix":"10.1007","volume":"87","author":[{"given":"Jing-Shan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Che","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Long","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Kuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ju","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,14]]},"reference":[{"key":"456_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nec.2005.10.005","volume":"17","author":"RR Lonser","year":"2006","unstructured":"Lonser RR, Oldfield EH (2006) Spinal cord hemangioblastomas. Neurosurg Clin N Am 17:37\u201344","journal-title":"Neurosurg Clin N Am"},{"key":"456_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneur.1976.00500060041009","volume":"33","author":"TR Browne","year":"1976","unstructured":"Browne TR, Adams RD, Roberson GH (1976) Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol 33:435\u2013441","journal-title":"Arch Neurol"},{"key":"456_CR3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.20090","volume":"55","author":"AO Vortmeyer","year":"2004","unstructured":"Vortmeyer AO, Yuan Q, Lee YS, Zhuang Z, Oldfield EH (2004) Developmental effects of von Hippel\u2013Lindau gene deficiency. Ann Neurol 55:721\u2013728","journal-title":"Ann Neurol"},{"key":"456_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006123-199807000-00018","volume":"43","author":"SD Chang","year":"1998","unstructured":"Chang SD, Meisel JA, Hancock SL, Martin DP, McManus M, Adler JRJ (1998) Treatment of hemangioblastomas in von Hippel\u2013Lindau disease with linear accelerator-based radiosurgery. Neurosurgery 43:28\u201334","journal-title":"Neurosurgery"},{"key":"456_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-004-5179-0","volume":"73","author":"G Ertas","year":"2005","unstructured":"Ertas G, Altundag MB, Ucer AR, Cankal F, Altundag K (2005) Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel\u2013Lindau disease: a case report and review of the literature. J Neurooncol 73:273\u2013275","journal-title":"J Neurooncol"},{"key":"456_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/PAP.0b013e31816f852e","volume":"15","author":"BM Shehata","year":"2008","unstructured":"Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H (2008) Von Hippel\u2013Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 15:165\u2013171","journal-title":"Adv Anat Pathol"},{"key":"456_CR7","first-page":"504","volume":"58","author":"JY Lee","year":"1998","unstructured":"Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, Chi JG, Zbar B, Lubensky IA, Linehan WM, Vortmeyer AO, Zhuang Z (1998) Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58:504\u2013508","journal-title":"Cancer Res"},{"key":"456_CR8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1349-7006.2006.00193.x","volume":"97","author":"K Hattori","year":"2006","unstructured":"Hattori K, Teranishi J, Stolle C, Yoshida M, Kondo K, Kishida T, Kanno H, Baba M, Kubota Y, Yao M (2006) Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel\u2013Lindau disease. Cancer Sci 97:400\u2013405","journal-title":"Cancer Sci"},{"key":"456_CR9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2362.2007.01806.x","volume":"37","author":"JS Huang","year":"2007","unstructured":"Huang JS, Huang CJ, Chen SK, Chien CC, Chen CW, CM L (2007) Associations between VHL genotype and clinical phenotype in familial von Hippel\u2013Lindau disease. Eur J Clin Invest 37:492\u2013500","journal-title":"Eur J Clin Invest"},{"key":"456_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2990.2002.00371.x","volume":"28","author":"SA Adams","year":"2002","unstructured":"Adams SA, Hilton DA (2002) Recurrent haemangioblastoma with glial differentiation. Neuropathol Appl Neurobiol 28:142\u2013146","journal-title":"Neuropathol Appl Neurobiol"},{"key":"456_CR11","first-page":"4568","volume":"85","author":"BU Bender","year":"2000","unstructured":"Bender BU, Gutsche M, Glasker S, Muller B, Kirste G, Eng C, Neumann HP (2000) Differential genetic alterations in von Hippel\u2013Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab 85:4568\u20134574","journal-title":"J Clin Endocrinol Metab"},{"key":"456_CR12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Tao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L (1993) Identification of the von Hippel\u2013Lindau disease tumor suppressor gene. Science 260:1317\u20131320","journal-title":"Science"},{"key":"456_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nprot.2006.104","volume":"1","author":"O Carrette","year":"2006","unstructured":"Carrette O, Burkhard PR, Sanchez JC, Hochstrasser DF (2006) State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research. Nat Protoc 1:812\u2013823","journal-title":"Nat Protoc"},{"key":"456_CR14","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1158\/1078-0432.CCR-06-1296","volume":"12","author":"FW Khwaja","year":"2006","unstructured":"Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG (2006) Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin Cancer Res 12:6331\u20136336","journal-title":"Clin Cancer Res"},{"key":"456_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/abio.2000.4837","volume":"287","author":"YG Tsay","year":"2000","unstructured":"Tsay YG, Wang YH, Chiu CM, Shen BJ, Lee SC (2000) A strategy for identification and quantitation of phosphopeptides by liquid chromatography\/tandem mass spectrometry. Anal Biochem 287:55\u201364","journal-title":"Anal Biochem"},{"key":"456_CR16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/ac00104a020","volume":"67","author":"JRr Yates","year":"1995","unstructured":"Yates JRr, Eng JK, McCormack AL, Schieltz D (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67:1426\u20131436","journal-title":"Anal Chem"},{"key":"456_CR17","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/pmic.200500811","volume":"6","author":"RA Craven","year":"2006","unstructured":"Craven RA, Hanrahan S, Totty N, Harnden P, Stanley AJ, Maher ER, Harris AL, Trimble WS, Selby PJ, Banks RE (2006) Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 6:3880\u20133893","journal-title":"Proteomics"},{"key":"456_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.2004.038414","volume":"76","author":"MP Goor van","year":"2005","unstructured":"van Goor MP, G\u00f3mez-Garc\u00eda EB, Leebeek FW, Brouwers GJ, Koudstaal PJ, Dippel DW (2005) The \u2212148 C\/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case\u2013control study. J Neurol Neurosurg Psychiatry 76:121\u2013123","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"456_CR19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L","volume":"192","author":"G Chambers","year":"2000","unstructured":"Chambers G, Lawrie L, Cash P, Murray GI (2000) Proteomics: a new approach to the study of disease. J Pathol 192:280\u2013288","journal-title":"J Pathol"},{"key":"456_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/CDLI.8.1.105-111.2001","volume":"8","author":"MA Smith","year":"2001","unstructured":"Smith MA, Bains SK, Betts JC, Choy EH, Zanders ED (2001) Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4. Clin Diagn Lab Immunol 8:105\u2013111","journal-title":"Clin Diagn Lab Immunol"},{"key":"456_CR21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1995","unstructured":"Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1995) von Hippel\u2013Lindau disease: genetic, clinical, and imaging features. Radiology 194:629\u2013642","journal-title":"Radiology"},{"key":"456_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-4608(96)00296-8","volume":"93","author":"HJ Decker","year":"1997","unstructured":"Decker HJ, Weidt EJ, Brieger J (1997) The von Hippel-Landau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet 93:74\u201383","journal-title":"Cancer Genet Cytogenet"},{"key":"456_CR23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood-2003-07-2550","volume":"103","author":"E Liu","year":"2004","unstructured":"Liu E, Percy MJ, Amos CI, Guan Y, Shete S, Stockton DW, McMullin MF, Polyakova LA, Ang SO, Pastore YD, Jedlickova K, Lappin TR, Gordeuk V, Prchal JT (2004) The worldwide distribution of the VHL 598C\u2009>\u2009T mutation indicates a single founding event. Blood 103:1937\u20131940","journal-title":"Blood"},{"key":"456_CR24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/10.7.763","volume":"10","author":"CA Friedrich","year":"2001","unstructured":"Friedrich CA (2001) Genotype-phenotype correlation in von Hippel\u2013Lindau syndrome. Hum Mol Genet 10:763\u2013767","journal-title":"Hum Mol Genet"},{"key":"456_CR25","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","volume":"170","author":"WM Linehan","year":"2003","unstructured":"Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163\u20132172","journal-title":"J Urol"},{"key":"456_CR26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.10807","volume":"55","author":"SD Wait","year":"2004","unstructured":"Wait SD, Vortmeyer AO, Lonser RR, Chang DT, Finn MA, Bhowmick DA, Pack SD, Oldfield EH, Zhuang Z (2004) Somatic mutations in VHL germline deletion kindred correlate with mild phenotype. Ann Neurol 55:236\u2013240","journal-title":"Ann Neurol"},{"key":"456_CR27","first-page":"552","volume":"117","author":"YR Huang","year":"2004","unstructured":"Huang YR, Zhang J, Wang JD, Fan XD (2004) Genetic study of a large Chinese kindred with von Hippel\u2013Lindau disease. Chin Med J (Engl) 117:552\u2013557","journal-title":"Chin Med J (Engl)"},{"key":"456_CR28","first-page":"3067","volume":"43","author":"H Dollfus","year":"2002","unstructured":"Dollfus H, Massin P, Taupin P, Nemeth C, Amara S, Giraud S, B\u00e9roud C, Dureau P, Gaudric A, Landais P, Richard S (2002) Retinal hemangioblastoma in von Hippel\u2013Lindau disease: a clinical and molecular study. Invest Ophthalmol Vis Sci 43:3067\u20133074","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"456_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02484514","volume":"21","author":"M Miyagami","year":"2004","unstructured":"Miyagami M, Katayama Y (2004) Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence. Brain Tumor Pathol 21:75\u201382","journal-title":"Brain Tumor Pathol"},{"key":"456_CR30","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1021\/bi00330a036","volume":"24","author":"B Dahlback","year":"1985","unstructured":"Dahlback B, Podack ER (1985) Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry 24:2368\u20132374","journal-title":"Biochemistry"},{"key":"456_CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1227\/01.NEU.0000153909.70381.C8","volume":"56","author":"S Gl\u00e4sker","year":"2005","unstructured":"Gl\u00e4sker S, Berlis A, Pagenstecher A, Vougioukas VI, Van Velthoven V (2005) Characterization of hemangioblastomas of spinal nerves. Neurosurgery 56:503\u2013509","journal-title":"Neurosurgery"},{"key":"456_CR32","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991\u20135004","journal-title":"J Clin Oncol"},{"key":"456_CR33","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1200\/JCO.2005.01.184","volume":"23","author":"G Schuch","year":"2005","unstructured":"Schuch G, de Wit M, H\u00f6ltje J, Laack E, Schilling G, Hossfeld DK, Fiedler W, Scigalla P, Jacobs MS (2005) Case 2. Hemangioblastomas: diagnosis of von Hippel\u2013Lindau disease and antiangiogenic treatment with SU5416. J Clin Oncol 23:3624\u20133626","journal-title":"J Clin Oncol"},{"key":"456_CR34","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1016\/S0021-9258(19)38738-1","volume":"265","author":"DM Tollefsen","year":"1990","unstructured":"Tollefsen DM, Weigel CJ, Kabeer MH (1990) The presence of methionine or threonine at position 381 in vitronectin is correlated with proteolytic cleavage at arginine 379. J Biol Chem 265:9778\u20139781","journal-title":"J Biol Chem"},{"key":"456_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-5793(90)81159-L","volume":"269","author":"D Chain","year":"1990","unstructured":"Chain D, Korc-Grodzicki B, Kreizman T, Shaltiel S (1990) The phosphorylation of the two-chain form of vitronectin by protein kinase A is heparin dependent. FEBS Lett 269:221\u2013225","journal-title":"FEBS Lett"},{"key":"456_CR36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/bj2740387","volume":"274","author":"D Chain","year":"1991","unstructured":"Chain D, Korc-Grodzicki B, Kreizman T, Shaltiel S (1991) Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A. Biochem J 274:387\u2013394","journal-title":"Biochem J"},{"key":"456_CR37","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1242\/jcs.108.4.1553","volume":"108","author":"SM Ribeiro","year":"1995","unstructured":"Ribeiro SM, Schultz-Cherry S, Murphy-Ullrich JE (1995) Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells. J Cell Sci 108:1553\u20131561","journal-title":"J Cell Sci"},{"key":"456_CR38","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1073\/pnas.1635112100","volume":"100","author":"M Yi","year":"2003","unstructured":"Yi M, Sakai T, Fassler R, Ruoslahti E (2003) Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc Natl Acad Sci U S A 100:11435\u201311438","journal-title":"Proc Natl Acad Sci U S A"},{"key":"456_CR39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1073\/pnas.80.5.1362","volume":"80","author":"DW Barnes","year":"1983","unstructured":"Barnes DW, Silnutzer J, See C, Shaffer M (1983) Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci U S A 80:1362\u20131366","journal-title":"Proc Natl Acad Sci U S A"},{"key":"456_CR40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/MCB.16.2.694","volume":"16","author":"D Parker","year":"1996","unstructured":"Parker D, Ferreri K, Nakajima T, LaMorte VJ, Evans R, Koerber SC, Hoeger C, Montminy MR (1996) Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 16:694\u2013703","journal-title":"Mol Cell Biol"},{"key":"456_CR41","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1242\/dev.128.9.1481","volume":"128","author":"S Pons","year":"2001","unstructured":"Pons S, Trejo JL, Martinez-Morales JR, Marti E (2001) Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation. Development 128:1481\u20131492","journal-title":"Development"},{"key":"456_CR42","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein. J Biol Chem 275:25733\u201325741","journal-title":"J Biol Chem"},{"key":"456_CR43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1242\/jcs.01617","volume":"118","author":"JL Ruas","year":"2005","unstructured":"Ruas JL, Poellinger L, Pereira T (2005) Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci 118:301\u2013311","journal-title":"J Cell Sci"},{"key":"456_CR44","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA, Kaur S, Coussens LM, Lengyel E (2008) The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 118:1367\u20131379","journal-title":"J Clin Invest"},{"key":"456_CR45","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1136\/jmg.39.7.e38","volume":"39","author":"C Cybulski","year":"2002","unstructured":"Cybulski C, Krzystolik K, Murgia A, Gorski B, Debniak T, Jakubowska A, Martella M, Kurzawski G, Prost M, Kojder I, Limon J, Nowacki P, Sagan L, Bialas B, Kaluza J, Zdunek M, Omulecka A, Jaskolski D, Kostyk E, Koraszewska-Matuszewska B, Haus O, Janiszewska H, Pecold K, Starzycka M, Slomski R, Cwirko M, Sikorski A, Gliniewicz B, Cyrylowski L, Fiszer-Maliszewska L, Gronwald J, Toloczko-Grabarek A, Zajaczek S, Lubinski J (2002) Germline mutations in the von Hippel\u2013Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene. J Med Genet 39:E38","journal-title":"J Med Genet"},{"key":"456_CR46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.70.5.644","volume":"70","author":"S Glasker","year":"2001","unstructured":"Glasker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP (2001) Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 70:644\u2013648","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"456_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1010623119469","volume":"52","author":"SH Sprenger","year":"2001","unstructured":"Sprenger SH, Gijtenbeek JM, Wesseling P, Sciot R, van Calenbergh F, Lammens M, Jeuken JW (2001) Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization. J Neurooncol 52:241\u2013247","journal-title":"J Neurooncol"},{"key":"456_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10147-004-0415-3","volume":"9","author":"T Shuin","year":"2004","unstructured":"Shuin T, Yamazaki I, Tamura K, Kamada M, Ashida S (2004) Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel\u2013Lindau disease. Int J Clin Oncol 9:283\u2013287","journal-title":"Int J Clin Oncol"},{"key":"456_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/nar\/26.1.256","volume":"26","author":"C Beroud","year":"1998","unstructured":"Beroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C (1998) Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26:256\u2013258","journal-title":"Nucleic Acids Res"},{"key":"456_CR50","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/302037","volume":"63","author":"AR Webster","year":"1998","unstructured":"Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER (1998) An analysis of phenotypic variation in the familial cancer syndrome von Hippel\u2013Lindau disease: evidence for modifier effects. Am J Hum Genet 63:1025\u20131035","journal-title":"Am J Hum Genet"},{"key":"456_CR51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ijc.1321","volume":"93","author":"K Minamiguchi","year":"2001","unstructured":"Minamiguchi K, Kumagai H, Masuda T, Kawada M, Ishizuka M, Takeuchi T (2001) Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis. Int J Cancer 93:307\u2013316","journal-title":"Int J Cancer"},{"key":"456_CR52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1073\/pnas.98.2.620","volume":"98","author":"M Yi","year":"2001","unstructured":"Yi M, Ruoslahti E (2001) A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci U S A 98:620\u2013624","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-009-0456-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0456-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T05:31:16Z","timestamp":1633239076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-009-0456-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,14]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s00109-009-0456-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,14]]}}}